It helps reduce appetite, control blood sugar, and support sustainable weight loss
In a phase 3 clinical trial, tirzepatide reduced 14.9% of body weight with a 5 mg dose, 19.5% with a 10 mg dose, and 20.9% with a 15 mg dose of tirzepatide
Body weight was obtained at baseline, 3, 6, 9 and 12 months after initiating semaglutide
It moves the conversation from what Tirzepatide does to how it does it inside the living human brain
Therefore, treatment with GLP-1RAs shows favorable effects on anti-inflammation through the suppression of these proinflammatory cytokine and inflammatory signal pathways, as well as augmenting cholesterol efflux in the endothelium
I., Islam, A